Literature DB >> 4930042

Classification of hyperlipidaemias and hyperlipoproteinaemias.

J L Beaumont, L A Carlson, G R Cooper, Z Fejfar, D S Fredrickson, T Strasser.   

Abstract

Many studies of atherosclerosis have indicated hyperlipidaemia as a predisposing factor to vascular disease. The relationship holds even for mild degrees of hyperlipidaemia, a fact that underlines the importance of this category of disorders. Both primary and secondary hyperlipidaemias represent such a variety of abnormalities that an internationally acceptable provisional classification is highly desirable in order to facilitate communication between scientists with different backgrounds.The present memorandum presents such a classification; it briefly describes the criteria for diagnosis of the main types of hyperlipidaemia as well as the methods of their determination. Because lipoproteins offer more information than analysis of plasma lipids (most of the plasma lipids being bound to various proteins), the classification is based on lipoprotein analyses by electrophoresis and ultracentrifugation. Simpler methods, however, such as the observation of plasma and measurements of cholesterol and triglycerides, are used to the fullest possible extent in determining the lipoprotein patterns.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4930042      PMCID: PMC2427808     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  Serum lipids in men with myocardial infarction.

Authors:  L A CARLSON
Journal:  Acta Med Scand       Date:  1960-08-31

2.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.

Authors:  L L ABEL; B B LEVY; B B BRODIE; F E KENDALL
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

Review 3.  Practical methods for plasma lipoprotein analysis.

Authors:  F T Hatch
Journal:  Adv Lipid Res       Date:  1968

4.  [Hyperlipidemia caused by anti-beta-lipoprotein autoantibodies. A new pathological entity].

Authors:  J L Beaumont
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1965-11-22

Review 5.  Circulating lipoproteins.

Authors:  V N Schumaker; G H Adams
Journal:  Annu Rev Biochem       Date:  1969       Impact factor: 23.643

6.  Evaluation of the purity of cholesterol primary standards.

Authors:  J H Williams; M Kuchmak; R F Witter
Journal:  Clin Chem       Date:  1970-05       Impact factor: 8.327

Review 7.  The analysis of human serum lipoprotein distributions.

Authors:  A M Ewing; N K Freeman; F T Lindgren
Journal:  Adv Lipid Res       Date:  1965

Review 8.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-05       Impact factor: 91.245

9.  Prepation of hypercholesterolemic and-or hypertriglyceridemic sera for lipid determinations.

Authors:  J H Williams; L Taylor; M Kuchmak; R F Witter
Journal:  Clin Chim Acta       Date:  1970-05       Impact factor: 3.786

10.  A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.

Authors:  D Seidel; P Alaupovic; R H Furman
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

View more
  112 in total

1.  Myocardial infarction in young women with special reference to oral contraceptive practice.

Authors:  J I Mann; M P Vessey; M Thorogood; S R Doll
Journal:  Br Med J       Date:  1975-05-03

2.  Silk and silkworm pupa peptides suppress adipogenesis in preadipocytes and fat accumulation in rats fed a high-fat diet.

Authors:  Sun Hee Lee; Dongsun Park; Goeun Yang; Dae-Kwon Bae; Yun-Hui Yang; Tae Kyun Kim; Dajeong Kim; Jangbeen Kyung; Sungho Yeon; Kyo Chul Koo; Jeong-Yong Lee; Seock-Yeon Hwang; Seong Soo Joo; Yun-Bae Kim
Journal:  Eur J Nutr       Date:  2011-12-13       Impact factor: 5.614

3.  [Relationship between the plasma concentration of the high density lipoproteins (HDL) and the intravenous fat tolerance in normo-and hypertriglyceridaemics].

Authors:  H J Lisch; S Sailer; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1978-08-15

4.  Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.

Authors:  L Kłosiewicz-Latoszek; W B Szostak
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  [Uric acid concentration in serum in different types of hyperlipoproteinemia, myocardial infarction and primary gout].

Authors:  U H Klemens; P von Löwis of Menar
Journal:  Klin Wochenschr       Date:  1975-04-15

Review 6.  The hypercholesterolaemia of obstructive jaundice.

Authors:  N McIntyre; D S Harry; A J Pearson
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

7.  Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension.

Authors:  A Lehtonen; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Splanchnic metabolism of plasma apolipoprotein B: studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects.

Authors:  P R Turner; N E Miller; C Cortese; W Hazzard; J Coltart; B Lewis
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

9.  Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region.

Authors: 
Journal:  Br Med J       Date:  1971-12-25

10.  Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.

Authors:  A M van den Maagdenberg; W Weng; I H de Bruijn; P de Knijff; H Funke; A H Smelt; J A Gevers Leuven; F M van't Hooft; G Assmann; M H Hofker
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.